Other News To Note
Bionovo Inc., of Emeryville, Calif., published preclinical data showing use of either estrogen or Bionovo's botanically derived tissue selective estrogen receptor modulators resulted in weight loss in mouse models of postmenopausal obesity. However, Bionovo's compounds did not adversely affect the breast or uterus, while estrogen stimulated proliferation of cells in the mammary gland and uterus. The data were published in the Journal of the Public Library of Science One.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.